Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: A meta-analysis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR=1.094, 95% CI=1.028-1.163, p=0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR=1.235, 95% CI=1.019-1.497, p=0.032 and OR=1.287, 95% CI=1.029-1.609, p=0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele=1.084, 95% CI=0.936-1.255, p=0.280, OR for the T allele=OR=0.847, 95% CI=0.706-1.270, p=0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.

Original languageEnglish
Pages (from-to)661-672
Number of pages12
JournalImmunological Investigations
Volume42
Issue number7
DOIs
Publication statusPublished - 2013 Sep 12

Fingerprint

Calcitriol Receptors
Ovarian Neoplasms
Meta-Analysis
Alleles
Population

Keywords

  • Meta-analysis
  • Ovarian cancer
  • Polymorphism
  • Vitamin D receptor

ASJC Scopus subject areas

  • Immunology

Cite this

@article{59183a0139e2457f87f387941013721a,
title = "Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer: A meta-analysis",
abstract = "Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR=1.094, 95{\%} CI=1.028-1.163, p=0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR=1.235, 95{\%} CI=1.019-1.497, p=0.032 and OR=1.287, 95{\%} CI=1.029-1.609, p=0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele=1.084, 95{\%} CI=0.936-1.255, p=0.280, OR for the T allele=OR=0.847, 95{\%} CI=0.706-1.270, p=0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.",
keywords = "Meta-analysis, Ovarian cancer, Polymorphism, Vitamin D receptor",
author = "Song, {Gwan Gyu} and Lee, {Young Ho}",
year = "2013",
month = "9",
day = "12",
doi = "10.3109/08820139.2013.822881",
language = "English",
volume = "42",
pages = "661--672",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Vitamin D receptor FokI, BsmI, ApaI, and TaqI polymorphisms and susceptibility to ovarian cancer

T2 - A meta-analysis

AU - Song, Gwan Gyu

AU - Lee, Young Ho

PY - 2013/9/12

Y1 - 2013/9/12

N2 - Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR=1.094, 95% CI=1.028-1.163, p=0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR=1.235, 95% CI=1.019-1.497, p=0.032 and OR=1.287, 95% CI=1.029-1.609, p=0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele=1.084, 95% CI=0.936-1.255, p=0.280, OR for the T allele=OR=0.847, 95% CI=0.706-1.270, p=0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.

AB - Objective: The goal of this study was to explore whether vitamin D receptor (VDR) polymorphisms are associated with susceptibility to ovarian cancer. Methods: Meta-analyses were conducted on the associations between the VDR FokI, BsmI, ApaI, and TaqI polymorphisms and ovarian cancer. Results: A total of 12 comparison studies were considered in the meta-analysis, which involved 3716 patients and 5059 controls. Meta-analysis of the VDR FokI polymorphism showed an association between ovarian cancer and the f allele in European populations (OR=1.094, 95% CI=1.028-1.163, p=0.004). Meta-analysis revealed an association between ovarian cancer and the ApaI A allele in all study subjects and Europeans as a sub-group (OR=1.235, 95% CI=1.019-1.497, p=0.032 and OR=1.287, 95% CI=1.029-1.609, p=0.027, respectively). No association was found between ovarian cancer and the BsmI and Taq polymorphisms (OR for B allele=1.084, 95% CI=0.936-1.255, p=0.280, OR for the T allele=OR=0.847, 95% CI=0.706-1.270, p=0.716). Conclusions: This meta-analysis suggests that the VDR FokI and ApaI polymorphisms are associated with susceptibility to ovarian cancer in European populations.

KW - Meta-analysis

KW - Ovarian cancer

KW - Polymorphism

KW - Vitamin D receptor

UR - http://www.scopus.com/inward/record.url?scp=84883563425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883563425&partnerID=8YFLogxK

U2 - 10.3109/08820139.2013.822881

DO - 10.3109/08820139.2013.822881

M3 - Article

C2 - 24004063

AN - SCOPUS:84883563425

VL - 42

SP - 661

EP - 672

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 7

ER -